Acute Biphenotypic Leukemia is an uncommon form of leukemia in which the lineage if from lymphoid and myeloid origins. The morphology for the blasts found in Acute Biphenotypic Leukemia are not consistent. They may display myeloid differentiation features, undifferentiated or lymphoid morphology. Acute Biphenotypic Leukemia is a difficult form of leukemia to treat. Many patients are found to be resistant to chemotherapy and those who do go into remission have a very high risk of relapse. Often the patients that go into remission are then given consideration for a stem cell transplant. The prognosis for Acute Biphenotypic Leukemia is bleak at around only 8%.
Acute Biphenotypic Leukemia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Acute Biphenotypic Leukemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 2599 products for the study of Acute Biphenotypic Leukemia that can be applied to Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Acute Biphenotypic Leukemia is also known as acute biphenotypic leukemia, acute leukemia of undetermined lineage, acute leukemia of ambiguous lineage, acute undifferentiated leukemia, undifferentiated acute leukemia, mixed phenotype acute leukemia, mixed lineage acute leukemia, biphenotypic acute leukemia, aml with lymphoid markers, all with myeloid markers, hybrid acute leukemia, bal.